miscsubjectsautonomous operating environment
Evidence review

SS-31 (Elamipretide) Mitochondrial Support for Gut: Evidence Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-gut`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-gut

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-gut/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-gut/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-gut/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

Gut barrier integrity depends on intestinal epithelial cells maintaining tight junctions and low oxidative stress. Mitochondrial dysfunction in these cells can increase reactive oxygen species, disrupt cardiolipin in the inner membrane, impair ATP production, and trigger apoptosis. This process weakens tight junction proteins such as ZO-1 and occludin. The result is higher paracellular permeability. Repair pathways that stabilize mitochondria can address the root layer rather than only downstream inflammation or symptoms.

Why SS-31 (Elamipretide) might help you

If mitochondrial oxidative stress and cardiolipin instability form part of your gut barrier challenge, SS-31 (Elamipretide) is discussed because it binds cardiolipin directly. Step one: the peptide accumulates in the inner mitochondrial membrane. Step two: it stabilizes cristae structure and supports electron transport chain efficiency. Step three: this reduces electron leak and ROS production while preserving ATP output. Step four: lower ROS can limit apoptosis and support maintenance of tight junction proteins. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus. SS-31 (Elamipretide) maps to the mitochondrial layer of intestinal epithelial cell health. No sibling peptides are in scope for this review.

What the evidence actually shows

Human data specific to gut: none identified. Preclinical data: one in-vitro study examined mycophenolic acid (MPA)-induced damage in intestinal epithelial cells. MPA increased ROS, reduced tight junction expression, and raised apoptosis. SS-31 treatment lowered intracellular and intramitochondrial ROS, upregulated tight junction proteins, and reduced apoptosis rates (preclinical tier, Deng et al. 2022, PMC9277164). Multiple rodent LPS models (LPS models systemic inflammation often linked to gut-derived endotoxins) showed SS-31 preserved mitochondrial membrane potential, reduced hippocampal oxidative stress, and improved behavioral outcomes, but these did not measure intestinal barrier endpoints directly (preclinical tier, Zhao et al. 2019). Broader mitochondrial studies in kidney and heart models confirm cardiolipin stabilization and ROS reduction in animal tissue (preclinical tier). No randomized human trials report gut permeability, microbiome, or intestinal histology outcomes.

What scientists say

Researchers describe SS-31 as a cardiolipin-targeting tetrapeptide that improves bioenergetics without acting as a general antioxidant. Reviews note consistent mitochondrial protection across cell types in culture and rodents, with emphasis on cristae preservation and reduced cytochrome c release. Clinical development has focused on primary mitochondrial myopathy, heart failure, and Barth syndrome; gut-specific applications remain exploratory (mechanistic tier, multiple reviews 2024-2025).

What people say on Reddit

Anecdotal reports in CFS and ME/CFS communities mention SS-31 primarily for energy and cognitive function. Some users note transient GI symptoms (nausea, diarrhea, hot flashes) during initial dosing that later resolved; others report no gut-specific benefits or changes. One user described fixing digestion first with other interventions before adding SS-31 for mitochondrial support (anecdotal tier, r/cfs threads 2025).

What people say on X

Limited public discussion. Posts focus on mitochondrial medicine in general or Barth syndrome approval rather than gut outcomes. No widespread user reports tie SS-31 directly to intestinal barrier improvements (anecdotal tier).

What we do not know

No human pharmacokinetic or efficacy data exist for intestinal epithelial mitochondria or gut permeability. Duration of effect on tight junctions, interactions with microbiome composition, and long-term outcomes in chronic gut conditions remain unstudied in controlled settings. Dose-response relationships specific to gut tissue are unknown.

Safety and limits

Human trials in non-gut indications report good short-term tolerability with injection-site reactions as the main observation. Some preclinical and anecdotal sources note possible transient GI distress. Long-term human safety beyond trial durations is not established. Evidence for gut applications rests entirely on mechanistic and limited preclinical layers.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 4 claims are extracted and stored on the object.
  • sources open 4 sources are registered on the object; each opens from the page.
  • claims bound 4 of 4 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/ss-31-gut/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/ss-31-gut/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/ss-31-gut?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/ss-31-gut/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

Gut lining / GI · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain 4c0cbe43ff1d · verify chain · provenance

Key evidence

4 claims · tier-ranked · API
preclinical
LPS rodent models show SS-31 preserves mitochondrial function under inflammatory stress, though gut barrier endpoints were not measured.
sources: s4
humanlow confidence
No human trials report effects of SS-31 on gut barrier function, permeability, or intestinal histology.
sources: s3
preclinicallow confidence
In an in-vitro model, SS-31 reduced MPA-induced ROS, upregulated tight junction proteins, and lowered apoptosis in intestinal epithelial cells.
sources: s2
mechanisticlow confidence
SS-31 binds cardiolipin in the inner mitochondrial membrane and stabilizes cristae structure.
sources: s1
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:54
SS-31 (Elamipretide) Mitochondrial Support for Gut: Evidence Review · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Gut
Slug: ss-31-gut
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_la
it output
{
  "slug": "ss-31-gut",
  "title": "SS-31 (Elamipretide) Mitochondrial Support for Gut: Evidence Review",
  "body": "## What's breaking down\n\nGut barrier integrity depends on intestinal epithelial cells maintaining tight junctions and low oxidative stress. Mitochondrial dysfunction in these cells can increase reactive oxygen species, disrupt cardiolipin in the inner membrane, impair ATP production, and trigger apoptosis. This process weakens tight junction proteins such as ZO-1 and occludin. The result is higher paracellular permeability. Repair pathways that stabilize mitochondria can address the root layer rather than only downstream inflammation or symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\nIf mitochondrial oxidative stress and cardiolipin instability form part of your gut barrier challenge, SS-31 (Elamipretide) is discussed because it binds cardiolipin directly. Step one: the peptide accumulates in the inner mitochondrial membrane. Step two: it stabilizes cristae structure and supports electron transport chain efficiency. Step three: this reduces electron leak and ROS production while preserving ATP output. Step four: lower ROS can limit apoptosis and support maintenance of tight junction proteins. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\n
477ff55f9f6d0b3c
Machine verification: /api/articles/ss-31-gut/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "LPS rodent models show SS-31 preserves mitochondrial function under inflammatory stress, though gut barrier endpoints were not measured."?
ask ss-31-gut claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials report effects of SS-31 on gut barrier function, permeability, or intestinal histology."?
ask ss-31-gut claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In an in-vitro model, SS-31 reduced MPA-induced ROS, upregulated tight junction proteins, and lowered apoptosis in intestinal epithelial cel…"?
ask ss-31-gut claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "SS-31 binds cardiolipin in the inner mitochondrial membrane and stabilizes cristae structure."?
ask ss-31-gut claim c1 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) Mitochondrial Support for Gut: Evidence Review — and what would you need me to tell you first?
ask ss-31-gut condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) Mitochondrial Support for Gut: Evidence Review (studies vs anecdotes)?
ask ss-31-gut good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fss-31-gut%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/ss-31-gut/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/ss-31-gut/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3